Blauvelt A, Draelos ZD, Gooderham M, Lain E, Moore AY, Papp KA, Zirwas M, Krupa D, Burnett P, Berk DR, Chu DH. Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial: Assessment of Pruritus. J of Skin [Internet]. 2023 Jul. 17 [cited 2024 Jul. 3];7(4):s226. Available from: https://jofskin.org/33014/index.php/skin/article/view/2193